Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma
Michal Sieniawski, Oliver Staak, Jan-Peter Glossmann, Thorsten Reineke, Helena Scheuß, Volker Diehl, Andreas Engert, Andreas JostingVolume:
86
Language:
english
Pages:
9
DOI:
10.1007/s00277-006-0210-5
Date:
February, 2007
File:
PDF, 178 KB
english, 2007